The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 入组人数
- 317
- 试验地点
- 1
- 主要终点
- Database creation
研究概览
简要总结
The long-term goal of our PIC is to develop effective strategies that can be applied clinically at the point-of-care to prevent, intercept, or detect PDAC at an early stage, thereby reducing PDAC burden and saving lives.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18 years of age or older
- •Moffitt Cancer Center patients presenting with a pancreatic cyst, and/or inherited syndrome that predisposes them to pancreatic ductal adenocarcinoma (PDAC)
- •Moffitt Cancer Center patients undergoing evaluation for localized/early stage PDAC.
- •Moffitt Cancer Center patients with a combination of PDAC risk factors such as a history of chronic or new-onset diabetes, pancreatitis, obesity, tobacco exposure, toxin exposure and/or heavy alcohol consumption.
排除标准
- 未提供
研究组 & 干预措施
All participants
Participants include patients scheduled to see the clinical team in the Pancreas Interception Center (PIC) which will be housed in the Moffitt GI Clinic.
干预措施: Data collection (Other)
结局指标
主要结局
Database creation
时间窗: 24 months
A centralized, real-time, queryable and secure database will be developed that will integrate data on Moffitt patients diagnosed with pancreatic ductal adenocarcinoma (PDAC), pancreatic cystic lesions (benign, pre-cancerous and malignant), or an inherited PDAC susceptibility.
次要结局
未报告次要终点
